SCHEMBL4833640

SCHEMBL4833640

COc1cccc2c1CC(C(=O)Cl)N2S(=O)(=O)c1ccc(-c2ccc(F)cc2F)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.41
ALDH1A1 P00352 1/20 0.39
MEN1 O00255 1/20 0.39
GFER P55789 1/20 0.39
KMT2A Q03164 1/20 0.39
GAA P10253 1/20 0.39
CMA1 P23946 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
GPR6 P46095 2/20 0.36
APLNR P35414 1/20 0.36
PTGS2 P35354 1/20 0.36
TRPA1 O75762 1/20 0.36
MAPT P10636 1/20 0.35
HTR2A P28223 1/20 0.35
GRM2 Q14416 1/20 0.35
AADAT Q8N5Z0 1/20 0.35
PAX8 Q06710 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4837892 0.92 GHSR (0.41) GHSRALDH1A1MEN1GFERKMT2A
SCHEMBL4841794 0.91 GHSR (0.42) GHSRALDH1A1MEN1GFERKMT2A
Hydrochloric Acid SCHEMBL4833643 0.91 GHSR (0.41) GHSRALDH1A1MEN1GFERKMT2A
SCHEMBL4832819 0.85 ALDH1A1 (0.41) ALDH1A1MEN1GFERKMT2AGAA
SCHEMBL4836738 0.84 ALDH1A1 (0.40) ALDH1A1MEN1GFERKMT2AGAA
SCHEMBL4845609 0.83 MAPT (0.41) GHSRALDH1A1LMNAHTTSMN1; SMN2
SCHEMBL4834048 0.82 TRPA1 (0.41) GHSRLMNAHTTTRPA1
SCHEMBL4843919 0.82 TRPA1 (0.41) GHSRLMNAHTTPTGS2TRPA1
SCHEMBL4833927 0.82 TRPA1 (0.41) LMNAHTTTRPA1
SCHEMBL4833211 0.81 ALDH1A1 (0.47) ALDH1A1MEN1GFERKMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 GHSR 251/4885ALDH1A1 1819/4885MEN1 2712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.